Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
808 studies found for:    Open Studies | "Bacterial Infections"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Bacterial Infections" (808 records)
Need help? See Downloading Content for Analysis
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown † Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation
2 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
3 Not yet recruiting Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Condition: Bacterial Infection
Intervention:
4 Recruiting Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
5 Recruiting Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection
Conditions: Febrile Shivering;   Severe Bacterial Infection
Intervention: Other: Ancillary tests
6 Recruiting Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Condition: Bacterial Infection
Intervention:
7 Unknown † The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
Conditions: Bacterial Infections;   Viral Infection
Intervention:
8 Recruiting Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Carbavance
9 Recruiting Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Condition: Bacterial Infections
Interventions: Drug: Imipenem+Cilastatin/Relebactam;   Drug: Colistimethate sodium (CMS);   Drug: Imipenem+Cilastatin;   Drug: Placebo to CMS
10 Recruiting A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Condition: Gram-Positive Bacterial Infections
Interventions: Drug: Tedizolid Phosphate (IV);   Drug: Tedizolid Phosphate (oral suspension)
11 Recruiting Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Condition: Bacterial Infection
Intervention: Drug: solithromycin
12 Recruiting Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants
Condition: Bacterial Infection
Intervention: Procedure: Analysis of the heart rate and respiratory characteristics / Telemonitoring system prototype developed by INSERM U-642
13 Recruiting Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
Condition: Gram-Negative Bacterial Infections
Interventions: Drug: Colistin;   Drug: Meropenem
14 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
15 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
16 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
Intervention:
17 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
18 Unknown † New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn
Condition: Nosocomial Infection
Intervention:
19 Recruiting Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department
Conditions: Systemic Inflammatory Response Syndrome;   Fever
Intervention: Biological: Procalcitonin (PCT) as a diagnostic marker of bacterial infection
20 Recruiting Staph Household Intervention for Eradication (SHINE)
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Staphylococcus Aureus;   MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Chlorhexidine;   Drug: Mupirocin;   Behavioral: Household cleaning
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years